Clinical analysis of 33 patients with adult T-cell leukemia (ATL)-diagnostic criteria and significance of high- and low-risk ATL

Int J Cancer. 1986 Mar 15;37(3):335-41. doi: 10.1002/ijc.2910370303.

Abstract

The clinical characteristics of 33 patients with adult T-cell leukemia (ATL) are described. All patients were born and have lived in Miyazaki Prefecture (southwest of Japan). Because of a wide range of clinical presentations and courses, they were subdivided into 2 groups. In the high-risk group, patients presented with high white-cell counts (WBC greater than or equal to 20,000/microliter) and over 30% of abnormal lymphoid cells (18 patients) and hypercalcemia with a low percentage of leukemic cells (5 patients). In this group the median survival time was only 3 months despite various modes of treatment. In contrast, patients of the second group exhibited a low percentage of abnormal lymphoid cells (WBC less than 20,000/microliter and/or leukemic cells less than 30%) and had no hypercalcemia (8 patients). Their clinical course was chronic with a median survival of 8 months, regardless of modalities of treatment. Two patients went through a period when the number of circulating leukemic cells was low (less than or equal to 5%) before overt leukemia appeared. Other clinical features, signs, symptoms, routine laboratory data, serum anti-ATL-associated antibody, cell membrane markers and cytogenetic studies were similar to those observed in other districts of Kyushu island.

MeSH terms

  • Adult
  • Aged
  • Antibodies, Neoplasm / analysis
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • DNA, Viral / analysis
  • Deltaretrovirus / genetics
  • Female
  • Humans
  • L-Lactate Dehydrogenase / blood
  • Leukemia / diagnosis*
  • Leukemia / drug therapy
  • Leukemia / mortality
  • Leukocyte Count
  • Male
  • Middle Aged
  • Risk
  • T-Lymphocytes

Substances

  • Antibodies, Neoplasm
  • DNA, Viral
  • L-Lactate Dehydrogenase